NFP Sampoorna Foods IPO: 12.76x P/E valuation

What is trending about this SME IPO

Social media discussion around the NFP Sampoorna Foods IPO is unusually valuation-led, with many posts highlighting a 12.76x P/E at the upper band. The offer is positioned as a book-built SME IPO proposed to list on the NSE SME platform. Most posts focus on whether the headline discount to listed peers is enough to compensate for SME liquidity and business risks. There is also debate on grey market signals, because different trackers are showing different GMP readings close to the opening date. Another frequently mentioned point is that the issue is a 100 percent fresh issue with no offer for sale, which changes how investors think about fund utilisation. Some creators are framing it as a fundamental, medium-to-long-term idea rather than a listing pop application. At the same time, the minimum ticket size and funding costs for leveraged applications are being circulated widely. Overall, the conversation is less about brand recall and more about pricing, ratios, and SME mechanics.

IPO dates, listing timeline, and platform

As shared across Reddit threads and IPO trackers, the IPO opens for subscription on 18 May 2026 and closes on 20 May 2026. The shares are proposed to be listed on the NSE SME platform, with a tentative listing date of 25 May 2026. Several posts also mention operational milestones after closure, including share credit to demat accounts by 22 May 2026. This timing matters for retail applicants because SME allotment timelines can be tight, and price discovery can be volatile around listing. A few social posts contain older, conflicting date schedules from early 2026, but the dominant chatter currently points to the May 2026 window. The cleaner way investors are handling this mismatch is by relying on the latest opening and closing dates being repeated across multiple sources. Subscription days also overlap with another IPO mentioned in commentary, which some users believe could split attention. Investors tracking SME IPO flows are watching this overlap as a practical demand-side factor.

Issue size, share count, and dilution math

The total issue size is discussed as 44,60,000 equity shares, aggregating up to ₹24.53 crore. The issue is described as a fresh issue of 44,60,000 shares, implying no secondary sell-down in this offering. Social posts also provide the shareholding base: pre-issue shareholding stands at 81,74,128 shares and is expected to rise to 1,26,34,128 shares post-issue. That increase matches the fresh issuance, so dilution math is straightforward from the disclosed counts. Because this is an SME issue, investors are also looking at how the larger post-issue equity base affects per-share metrics like EPS. Some trackers explicitly show both pre-IPO and post-IPO EPS figures, which is why P/E discussions often mention which EPS base is used. The focus is not just on valuation at offer price, but also on how the metrics look after new capital comes in. This also explains why there are multiple EPS numbers circulating at the same time.

Price band, lot size, and application amount

The price band is fixed at ₹52 to ₹55 per share, with a face value of ₹10 per share. The lot size is 2,000 shares, so the minimum application size is one lot. At the upper band of ₹55, the minimum cheque size works out to ₹1,10,000, and this figure is widely shared in posts. Some social commentary also contains a much smaller minimum investment number, but it conflicts with the lot size and price band arithmetic being posted elsewhere. Because SME IPOs have a higher minimum ticket, many retail users are discussing whether to apply cash-only or use funding. One table in circulation mentions an NII funding cost per share of ₹22.10, indicating the cost sensitivity for leveraged applications. This is also why break-even price is being discussed alongside expected listing behavior. In short, most retail decision-making in the threads starts with the ₹1.10 lakh minimum outlay and works backward to risk appetite.

Business snapshot being shared online

Creators describe NFP Sampoorna Foods as a New Delhi-based company involved in procuring, importing, processing, packaging, grading, marketing, and distributing dry fruits. The product mentions across posts include cashew nuts, makhana (fox nuts), almonds, and walnuts. One frequently repeated point is that sales are largely domestic, even when some raw material is sourced internationally. The business model breakdown shared in video summaries highlights three channels: B2B wholesale, B2C via e-commerce, and B2G or institutional sales. B2B is repeatedly described as the dominant revenue driver, with references to the Khari Baoli wholesale market in Delhi as a key ecosystem. Some posts also mention sourcing from Indian markets as well as African origins for cashews, which is then tied to import dependency risk. The company is also described as having operations linked to Rajasthan in the discussion. These points are being used to argue that the model can scale, but may face commodity and procurement volatility.

The 12.76x P/E: what it actually means here

The central valuation claim in social chatter is that the IPO is priced at about 12.76 times FY25 EPS of ₹4.31 at the upper price of ₹55. This is being framed as a discount compared with certain listed peers in a similar dry fruit and packaged food space. Users are treating the multiple as a quick screening tool, especially because SME IPOs often come with limited publicly discussed benchmarks. Several posts also mention that post-issue EPS is lower than pre-issue EPS, reflecting dilution, so investors are checking which EPS base is being used in each calculation. Alongside P/E, RoNW is being cited as a support metric, with one widely shared figure at 29.65 percent. Other metric snapshots circulating include ROCE, debt-to-equity, and margins, but not all posts use the same values. Importantly, the P/E alone is not being treated as a guarantee of listing gains, particularly because GMP signals being cited are mixed. The more grounded interpretation in threads is that 12.76x is a headline valuation anchor, not a complete risk-adjusted conclusion.

Peer and metric table cited in posts

A structured peer comparison table is circulating on social media, and it is driving much of the “discount to peers” argument. Users are also sharing a summary of IPO terms and the dilution numbers to keep the basics in one place.

Profitability ratios and balance sheet talking points

Beyond P/E, Reddit users are discussing capital efficiency and leverage because SME businesses can swing quickly with working capital cycles. ROCE is shown as 24.71 percent in one valuation snapshot, while another post mentions higher ROCE figures, indicating inconsistent sources. Debt-to-equity is also inconsistent across posts, appearing as 1.59 in one place and 1.26 in another, but the common takeaway is that leverage is meaningful. Margin numbers are also being shared in multiple versions, including PAT margin and EBITDA margin, again with different values in different trackers. A separate set of EPS numbers also appears: EPS pre-IPO and post-IPO are quoted differently across sources, reinforcing the need to check what period and base is being used. Still, the discussion remains focused on the idea that returns metrics like RoNW are strong on paper for a distribution and processing model. At least one social post explicitly flags the higher debt-to-equity ratio as a risk factor. This combination is why threads often conclude that the valuation looks optically reasonable, but the balance sheet and cash cycle matter just as much.

GMP, funding chatter, and conflicting signals

Grey market premium is one of the most debated points in the conversation, because values shared are not consistent. Some posts cite a GMP of ₹8, or 14.55 percent, while others say GMP is nil at ₹0 as of 15 May 2026. The practical takeaway in threads is that GMP can change quickly and can differ by source, so it should not be treated as a single definitive indicator. Separately, funding-related chatter is strong, including a table that mentions an NII funding cost per share of ₹22.10. That number is being used to estimate break-even levels for leveraged applications, especially if listing is flat. Users are also highlighting that SME IPOs can have liquidity constraints after listing, which can amplify both gains and drawdowns. Some commentary frames the issue as better suited to investors who can hold through volatility rather than those seeking a quick exit. The mixed GMP prints are reinforcing that cautious stance. Overall, sentiment is present, but not uniformly bullish in the way some hot SME issues are.

Risks and flags repeatedly mentioned online

The most repeated risk label is SME IPO liquidity risk, including concerns about wider spreads and smaller free float dynamics. Competitive intensity in dry fruits and packaged food distribution is also being flagged, since many players operate with similar sourcing and channel strategies. Import dependency is specifically mentioned in relation to African cashews, which some users connect to currency and supply variability. Debt-to-equity being above 1 in shared snapshots is another recurring point, because it can make working capital swings more painful. A notable thread of discussion also mentions an earlier postponement from February 2026, plus a market maker change and an added underwriter, which some users treat as red flags. Another risk line shared in posts is “near-zero QIB allocation”, presented as something to examine closely before applying. Promoter acquisition cost is also being discussed, with posts stating promoters acquired shares around ₹10 to ₹11.79 versus the IPO band of ₹52 to ₹55. None of these items automatically invalidate the valuation case, but they explain why many posts frame it as a conviction-driven SME bet rather than a low-risk trade.

How social media is framing the decision

The dominant framing is that the IPO looks cheaper than some listed peers on a simple P/E screen, but investors should not stop at the headline multiple. Those supportive of the issue cite the 12.76x FY25 P/E and the RoNW figure being higher than the two named peers in shared tables. More cautious voices point to mixed GMP, SME liquidity risk, leverage, and sourcing risks. Several posts explicitly advise checking the most recent quarterly numbers before applying, implying FY25 alone may not tell the whole story. Others highlight that the issue is fully fresh, which can be positive if funds are used efficiently, but the specific end-use claims vary across posts. A practical subset of users is simply focusing on whether the risk-reward works with a ₹1.10 lakh minimum application size. In that sense, the IPO is being treated as a portfolio allocation question rather than a simple “apply or skip” listing gain call. The clearest consensus in the discussion is that, based on the mixed GMP prints, expectations of guaranteed listing premium are low. The decision, as framed online, comes down to whether the P/E discount is enough compensation for SME-specific risks.